![Albert W. Gianchetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert W. Gianchetti
Directeur Général chez
Nuevocor Pte Ltd.
Profil
Albert W.
Gianchetti is Chief Executive Officer & Director at Nuevocor Pte Ltd. since 2026.
Former roles include President, Chief Executive Officer & Director at Xylocor Therapeutics, Inc., Chief Commercial Officer & Senior Vice President at Vanda Pharmaceuticals, Inc. from 2007 to 2008, and Vice President-Global Commercial Strategy at GSK Plc.
Education includes an MBA from Drexel University and an undergraduate degree from the University of Delaware.
Postes actifs de Albert W. Gianchetti
| Sociétés | Poste | Début |
|---|---|---|
Nuevocor Pte Ltd.
 Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapy for cardiac diseases | Directeur Général | 08/01/2026 |
Anciens postes connus de Albert W. Gianchetti
| Sociétés | Poste | Fin |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/12/2008 |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Directeur Général | - |
| GSK PLC | Corporate Officer/Principal | - |
Formation de Albert W. Gianchetti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Nuevocor Pte Ltd.
Nuevocor Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapy for cardiac diseases | Health Technology |
